News & Events
News & Events
Case Western Reserve and Atelerix Life Sciences Inc. sign option license to develop new therapeutic approach to opioid crisis
Novel small molecule technology reverses life-threatening opioid-induced respiratory depression without diminishing pain relief Case Western Reserve University and Atelerix Life Sciences Inc., a Charlottesville, Virginia-based
Atelerix Life Sciences Announces Publication Demonstrating Reversal of Opioid Induced Respiratory Depression
CHARLOTTESVILLE, VA, UNITED STATES, May 19, 2021 /EINPresswire.com/ — Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company developing novel small molecule therapeutics for the
Atelerix Life Sciences Appoints James Bates as CMO
CHARLOTTESVILLE, VA, UNITED STATES, September 14, 2021 /EINPresswire.com/ — Atelerix Life Sciences Inc., a leader in new therapeutics for unmet medical needs related to opioid
Peter Barton Hutt Joins Atelerix Life Sciences Board of Directors
Distinguished Counsel and FDA Regulatory Scholar Will Lend His Expertise on Corporate and Strategic Matters His extensive experience and knowledge of life sciences, including expertise
Atelerix Life Sciences Inc. Awarded $1.84M SBIR Grant From NIH (NHLBI)
Funds will Support Recent Seed Round Financing Leading to First-in-Human Testing Charlottesville, VA, September 19, 2022. Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company
Atelerix Life Sciences Inc. Announces Signing of Exclusive Technology License Agreement with Case Western Reserve University
Novel small molecule technology reverses life-threatening drug induced respiratory depression without diminishing pain relief Charlottesville, VA, July 1, 2023. Atelerix Life Sciences Inc., a Charlottesville,